insight-logo

The (Almost) Unstoppable Rise of Finnish Health Tech

MedEngine achieves very strong growth in 2017 by combining medical data with pharmaceutical business expertise

In Press: Real-world treatment outcomes of vedolizumab among Finnish IBD patients (FINVEDO)

Holiday Special – MedEngine Office Dogs

Slush 2017 – Nothing normal ever changed a damn thing.

MedEngine welcomes Mirkka Koivusalo, Heidi Loponen, and Hanni Uusi-Kerttula

Mastering modern medical affairs

MedEngine presented results from three new studies at the ISPOR congress in Glasgow

12345...9